Investment Rating - The report assigns a "Buy" rating for the company, marking the first coverage of the stock [1]. Core Views - The company is a leader in the precision gear industry, focusing on the automotive sector and expanding into the robot reducer market, which is expected to drive future growth [7][12]. - The company has a strong market position in the differential gear segment, with a significant market share and a growing revenue stream from its complete differential assembly business [12][22]. - The transition towards electric vehicles is creating new opportunities for the company, particularly in lightweight aluminum components and robot joint technology [57][69]. Summary by Sections 1. Company Overview - Established in 1992 and listed in 2011, the company specializes in precision gears for automotive applications, including differential gears and transmission components [12]. - The company has a diverse customer base, including major domestic and international automotive manufacturers [18]. 2. Financial Performance - The company reported total revenue of 20.25 billion yuan in 2024, a decrease of 3.7% year-on-year, with a net profit of 1.60 billion yuan, down 32.8% [20]. - Revenue is projected to grow to 23.06 billion yuan by 2025, with net profit expected to reach 2.41 billion yuan [1]. 3. Market Position - The company holds the largest market share in the differential gear sector in China, benefiting from high entry barriers in the capital-intensive industry [42][43]. - The market for differential assemblies is expected to grow significantly, with projections of 71.51 billion yuan by 2025 [54]. 4. Product Development - The company is expanding its product offerings to include lightweight aluminum components, which are crucial for meeting the demands of electric vehicles [57][69]. - The company has initiated projects to produce aluminum alloy parts, with planned capacities of 700,000 and 800,000 units for steering knuckles and control arms, respectively [71]. 5. Strategic Initiatives - The company is actively pursuing partnerships in the robotics sector, having established a joint venture to develop precision reducers for robotic applications [12][56]. - The company is enhancing its production capabilities through capital increases and convertible bonds to support its growth in the differential assembly market [55].

Group 1: Policy and Economic Outlook - The report highlights a potential easing of trade tensions between the US and China, with a significant phone call between President Trump and President Xi Jinping contributing to a positive market sentiment [1][2] - US employment data shows resilience, with April JOLTS job openings at 7.391 million and May non-farm payrolls increasing by 139,000, surpassing expectations [1][2] - Geopolitical tensions are also easing, as Russia and Ukraine engage in direct negotiations for peace, which positively impacts market sentiment [1] Group 2: Market Performance - The report indicates that developed markets rose by 1.3% and emerging markets increased by 2.2% during the week [5] - US stock markets are expected to experience a short-term upward trend, driven by both hard and soft economic data improvements [2] - The Nasdaq led gains with a 2.2% increase, while the S&P 500 and Dow Jones rose by 1.5% and 1.2%, respectively [5] Group 3: Bond Market Insights - The report notes that better-than-expected non-farm payroll data has suppressed interest rate cut expectations, leading to a 10 basis point rise in long-term interest rates [2][3] - Despite short-term upward risks for long-term US Treasury yields, the report anticipates a long-term downward trend due to concerns over US fiscal sustainability [3] Group 4: Sector and Investment Trends - The report observes a cautious optimism towards Hong Kong stocks, with the Hang Seng Technology Index rising by 2.3% and the Hang Seng Index by 2.2% [6] - There is a notable increase in gold ETF holdings, particularly in SPDR Gold Trust, which saw inflows of $433 million [6] - Global stock ETFs experienced a net inflow of $7.939 billion, while bond ETFs saw a more significant net inflow of $11.829 billion [26]

证券研究报告·行业跟踪周报·电力设备 电力设备行业跟踪周报 海外算力催化利好 AIDC，欧洲电动车再超 预期 增持（维持） [Table_Tag] [Table_Summary] 投资要点 2025 年 06 月 08 日 证券分析师 曾朵红 执业证书：S0600516080001 021-60199793 zengdh@dwzq.com.cn 证券分析师 阮巧燕 执业证书：S0600517120002 021-60199793 ruanqy@dwzq.com.cn 研究助理 许钧赫 执业证书：S0600123070121 xujunhe@dwzq.com.cn 行业走势 -14% -10% -6% -2% 2% 6% 10% 14% 18% 22% 26% 2024-6-11 2024-10-9 2025-2-6 2025-6-6 电力设备 沪深300 相关研究 《马斯克回归 Optimus 量产在即，汽 车反"内卷式"竞争》 2025-06-02 《关税缓和需求小幅向上，固态新技 术如火如荼》 2025-06-02 东吴证券研究所 1 / 43 请务必阅读正文之后的免责声明部分 ◼ 电气设备 6714 上 ...

Group 1 - The report highlights a positive outlook for growth stocks in the technology sector, driven by a favorable monetary environment and supportive government policies, with a focus on themes such as new consumption, innovative pharmaceuticals, and AI applications [3][12][36] - The North Exchange A-share market shows strong performance with an average market capitalization of 3.053 billion yuan and a daily trading volume of 24.834 billion yuan, although liquidity has decreased by 19.20% compared to the previous week [26][28] - The North Exchange will launch the North Exchange Specialized and Innovative Index on June 30, 2025, which will include 50 large-cap "little giant" companies to reflect the overall performance of specialized and innovative enterprises [12][13][36] Group 2 - The North Exchange A-share market is characterized by high attention and frequent short-term surges in stock prices, with a current PE ratio of 51.96, significantly higher than other markets [7][36] - The report suggests focusing on leading companies in niche sectors with valuation advantages and strong financial performance, as the market is expected to continue its structural rotation [3][36] - The report notes that the North Exchange has gathered 138 specialized and innovative "little giant" companies with a total market capitalization of 423.693 billion yuan, accounting for 53.25% of the total market capitalization of the North Exchange [12][36]

Group 1 - The electronic industry is experiencing a significant recovery in H1 2025, with Q1 revenue reaching 859.5 billion yuan, a year-on-year increase of 18%, and net profit of 36.6 billion yuan, up 30% year-on-year [14][21][20] - The semiconductor sector is seeing improvements across various segments, with power and analog ICs recovering, while digital ICs are benefiting from AI demand, showing around 20% growth in revenue and profit [18][20] - Inventory levels are slightly elevated, with total inventory at 678.7 billion yuan in Q1 2025, reflecting a 9% increase, while inventory turnover days rose from 73 days in Q4 2024 to 81 days in Q1 2025 [21][22] Group 2 - The consumer electronics sector is witnessing a surge in shipments, with smartphones, PCs, and tablets showing year-on-year growth of 1.5%, 4.9%, and 8.5% respectively in Q1 2025, driven by tariff fluctuations and subsidy policies [24][25][26] - AI has become a core driver for new product launches, with major manufacturers accelerating the development of AI systems and software ecosystems to enhance hardware capabilities [27][29] - The market is seeing innovative form factors, such as foldable PCs and desktop robots, with Huawei's MateBook series entering the traditional PC market, indicating a shift towards new computing paradigms [40][43] Group 3 - In the IC design sector, the analog segment is expected to see a turning point in 2025, with demand from automotive and industrial applications driving growth, while the storage segment is also on an upward cycle [2][3] - The SoC market is evolving with differentiated IP demands driven by various application scenarios, particularly in AI and ISP technologies [2][3] - The trend of large companies developing their own chips is increasing, with significant capital expenditures expected from major players like ByteDance and Alibaba, which will boost demand for custom IP and services [2][3] Group 4 - The equipment sector is focusing on domestic testing lines and the expansion of HBM production, with a notable slowdown in capital expenditure growth among fab plants [6][3] - The domestic market for storage and logic testing machines is expected to replicate the previous year's equipment market trends, with significant breakthroughs anticipated [6][3] - The overall outlook for computing hardware remains positive, with expectations of growth driven by both overseas and domestic advancements in AI technology [8][3]

Investment Rating - The report maintains an "Overweight" rating for the construction decoration industry [1] Core Viewpoints - Significant attention is being given to major infrastructure projects, with recommendations for sectors such as water conservancy and cleanroom engineering, which are experiencing structural prosperity [1] - In the first four months of 2025, China's infrastructure investment grew by 5.8% year-on-year, with water management investment increasing by 30.7%, water transport investment by 26.9%, and air transport investment by 13.9% [10][11] - The report highlights the potential for overseas engineering demand to remain robust, particularly in countries involved in the Belt and Road Initiative, with new contract amounts reaching $64.54 billion, a year-on-year increase of 17.4% [11] - The report suggests focusing on companies with transformation layouts in high-demand sectors such as energy conservation, carbon reduction, and new energy-related infrastructure [11] Summary by Sections Industry Dynamics - The central government plans to support urban renewal actions in 20 cities, with a budget exceeding 20 billion yuan, aimed at improving urban infrastructure [13][14] - The Ministry of Housing and Urban-Rural Development will enhance supervision to ensure the implementation of new residential project standards, promoting high-quality construction and the use of new materials [15] Market Performance - The construction decoration sector saw a weekly increase of 1.25%, outperforming the CSI 300 and Wind All A indices, which increased by 0.88% and 1.61%, respectively [18] - Notable stock performances included Zhongheng Design and Chongqing Construction, which saw significant weekly gains [19] Company Recommendations - The report recommends focusing on leading state-owned enterprises and local state-owned enterprises with stable performance and low valuations, such as China Communications Construction, China Electric Power Construction, and China Railway [10][11]

Investment Rating - The report maintains an "Overweight" rating for the retail industry [1] Core Insights - The report highlights the upcoming inclusion of companies Bruker, Guming, and Mixue Group into the Hong Kong Stock Connect, indicating potential investment opportunities in new consumer sectors [4][9] - Bruker, as the leading building block toy brand in China, has achieved a market share of 30.3% in 2023, with a global market share of 7.4%. The company is expected to continue its rapid growth through new IP and product launches [4][9] - Guming, the leading ready-to-drink tea brand in China, has expanded its store count to 9,914 by the end of 2024, with a projected GMV of 22.4 billion yuan. The company is well-positioned to capture market share through its differentiated competitive advantages [4][10] - Mixue Group, a leader in affordable ready-to-drink beverages, has established a comprehensive supply chain and has expanded to 45,302 stores by September 2024. The company holds a 31% market share in the sub-10 yuan price segment [4][10] - The report suggests focusing on the newly included consumer brands and highlights the potential for increased brand value and market share due to changing consumer habits [4][11] Summary by Sections Industry Trends - The report notes a 1.29% increase in the retail index from June 2 to June 6, 2025, and a year-to-date increase of 9.30% [12][23] Company Valuation Table - The report includes a valuation table for various companies, indicating their market capitalization and projected earnings [21] Market Performance - The report provides insights into the performance of various indices, with the retail index showing a positive trend compared to other sectors [12][22]

Investment Rating - The report maintains an "Overweight" rating for the non-bank financial sector [1] Core Views - The fundamentals of the non-bank financial sector are improving, with low valuations and expectations for policy catalysts [1] - The insurance sector is expected to benefit from economic recovery and rising interest rates, while the securities sector is poised for growth due to favorable market conditions and policy support [44] Summary by Sections 1. Recent Performance of Non-Bank Financial Sub-Sectors - All sub-sectors of non-bank financials outperformed the CSI 300 index in the recent four trading days, with the securities sector rising by 2.55%, multi-financial by 2.22%, and insurance by 1.03% [8][10] - Year-to-date, the insurance sector has performed the best, followed by multi-financials, while the securities sector has seen a decline [9] 2. Non-Bank Financial Sub-Sector Insights 2.1 Securities - Trading volume has significantly increased year-on-year, with June's average daily trading volume at 13,631 billion yuan, up 65.74% from last year [13] - The China Securities Regulatory Commission (CSRC) is committed to deepening reforms in the capital market, including enhancing the registration system for stock issuance and supporting mergers and acquisitions [17][18] 2.2 Insurance - Life insurance premiums have shown signs of recovery, with original premiums for personal insurance reaching 20,966 billion yuan in the first four months of 2025, a year-on-year increase of 1.8% [20] - The insurance sector's investment in equities has increased, with the total investment balance reaching 34.93 trillion yuan, up 16.7% year-on-year [23] 2.3 Multi-Financial - The trust industry is entering a stable transition period, with total trust assets growing to 29.56 trillion yuan, a year-on-year increase of 23.58% [31] - The futures market saw a significant increase in trading volume and value in April 2025, with a total transaction volume of 8.09 billion contracts and a transaction value of 70.18 trillion yuan, up 21.49% and 23.92% year-on-year, respectively [36] 3. Industry Ranking and Key Company Recommendations - The report ranks the non-bank financial sectors as follows: insurance > securities > other multi-financials, with key recommendations including New China Life Insurance, China Pacific Insurance, China Life Insurance, China Ping An, CITIC Securities, Tonghuashun, and Jiufang Zhitu Holdings [44]

Investment Rating - The report maintains an "Overweight" rating for the construction decoration industry [1] Core Viewpoints - Significant attention is being given to major infrastructure projects, with recommendations for sectors such as water conservancy and cleanroom engineering, which are experiencing structural prosperity [1] - In the first four months of 2025, China's infrastructure investment increased by 5.8% year-on-year, with water management investment growing by 30.7%, water transport investment by 26.9%, and air transport investment by 13.9% [10][11] - The report highlights the potential for overseas engineering demand to remain robust, particularly in countries involved in the Belt and Road Initiative, with new contracts signed amounting to USD 64.54 billion, a year-on-year increase of 17.4% [11] - The report suggests focusing on companies with transformation layouts in high-demand sectors such as energy conservation, carbon reduction, and new energy-related infrastructure [11] Summary by Sections Industry Dynamics - The central government plans to support urban renewal actions in 20 cities, with a budget exceeding 20 billion yuan, which is expected to boost demand for related engineering and materials [13][14] - The Ministry of Housing and Urban-Rural Development will enhance supervision to implement new residential project standards, promoting the application of new construction technologies and materials [15] Market Performance - The construction decoration sector saw a weekly increase of 1.25%, outperforming the CSI 300 and Wind All A indices, which increased by 0.88% and 1.61%, respectively [18] - Notable stock performances include Zhongheng Design and Chongqing Construction, which saw significant weekly gains of 26.5% and 26.1%, respectively [19] Recommendations - The report recommends focusing on leading state-owned enterprises and local state-owned enterprises in the infrastructure sector, which are expected to see valuation recovery opportunities [10] - Specific stock recommendations include China Communications Construction, China Electric Power Construction, and China Railway [10]

Investment Rating - The report maintains an "Overweight" rating for the pharmaceutical and biotechnology industry [1] Core Insights - Chinese innovative drugs performed beyond expectations at the ASCO conference, highlighting companies such as Innovent Biologics and Kelun-Biotech as key players [1][2] - The report emphasizes the growth potential in the innovative drug sector, with specific recommendations for stock selection based on growth, valuation, and dividend yield [11][12] Summary by Sections Industry Performance - The A-share pharmaceutical index has increased by 1.1% this week and 7.8% year-to-date, outperforming the CSI 300 by 0.3% and 9.4% respectively [10] - The Hong Kong biotechnology index rose by 4.5% this week and 47.8% year-to-date, also outperforming the Hang Seng Technology Index [10] Innovative Drug Developments - The ASCO conference showcased 73 oral presentations from China, marking a historical high, with significant contributions in ADC and dual-antibody research [5][16] - Notable advancements include the FDA IND approval for the first circular RNA drug by Huanma Biotech and the NDA submission for the first oral PROTAC estrogen receptor degrader by Arvinas and Pfizer [2] Stock Selection Strategy - Recommended sub-industry rankings for investment are: Innovative Drugs > CXO > Traditional Chinese Medicine > Medical Devices > Pharmacies > Pharmaceutical Commerce [11] - Growth-oriented stock picks include Innovent Biologics, Zai Lab, BeiGene, Kelun-Biotech, and others in the innovative drug space [11] - For undervalued stocks, focus on traditional Chinese medicine companies such as Zhaoli Pharmaceutical and Tianshili [11] Market Trends - The report notes a significant increase in licensing deals for Chinese innovative drugs, with 94 transactions totaling $51.9 billion in 2024, reflecting a 26% year-on-year growth [17] - The report highlights the strong performance of specific stocks, including Yiming Pharmaceutical and Wanbangde, which saw increases of 33% this week [10]